Tag: Boehringer Ingelheim
Owkin’s AI scientist lands at Boehringer Ingelheim labs
Boehringer Ingelheim licenses Owkin's K Pro AI scientist and multimodal oncology and immunology data.
Boehringer Ingelheim taps Immunai AI platform in $15 million deal
Boehringer Ingelheim pays $15M for Immunai's AI platform to find shared T-cell targets across cancer and autoimmune disease.